Publication
Title
Customizing systemic therapy in patients with advanced non-small cell lung cancer
Author
Abstract
Lung cancer is the leading cause of cancer deaths worldwide. Standard chemotherapy has been shown to improve quality of life and has a modest influence on overall survival. This modest improvement in survival is partly due to the choice of chemotherapy regimens that have been based on prognostic factors such as age, performance status and comorbidities of the patient. This underlines the importance of developing a more personalized therapy for patients with non-small cell lung cancer. Such an approach may reduce the variation in how individual patients respond to medications by tailoring therapies to their genetic profile. In this review we focus on several aspects of customized therapy, looking not only at patient characteristics but also to tumor histology and specific tumor biomarkers.
Language
English
Source (journal)
Therapeutic advances in medical oncology. - London, 2009, currens
Publication
London : Sage, 2011
ISSN
1758-8340
Volume/pages
3:4(2011), p. 207-218
Full text (Publishers DOI)
UAntwerpen
Faculty/Department
Research group
Publication type
Subject
Affiliation
Publications with a UAntwerp address
External links
Record
Identification
Creation 07.05.2012
Last edited 18.07.2014
To cite this reference